Literature DB >> 23930438

Surgical prevention and treatment of lymphedema after lymph node dissection in patients with cutaneous melanoma.

F Boccardo1, F De Cian, C C Campisi, L Molinari, S Spinaci, S Dessalvi, G Talamo, Caterina Campisi, G Villa, C Bellini, A Parodi, P L Santi, C Campisi.   

Abstract

Despite the development of minimal access dissection techniques, use of superficial groin dissection alone, and other recommendations to reduce morbidity in melanoma treatment, the incidence of lymphedema is still significant. The purpose of the current study was to assess the efficacy of microsurgical methods to limit the morbidity of inguinal lymphadenectomy. We conducted a retrospective review of patients who underwent groin dissection for melanoma treatment from February 2006 to April 2009. A total of 59 melanoma patients with positive groin lymph nodes comprised 18 patients (T-group) with melanoma in the trunk and 41 patients (E-group) who had melanoma in an extremity and currently have lymphedema. The T-group patients underwent primary prevention of lymphedema with microsurgical lymphatic-venous anastomoses (LVA) performed simultaneously with groin dissection. The E-group patients underwent LVA to treat the secondary lymphedema after an accurate oncological and lymphological assessment. Limb volume measurements and lymphoscintigraphy were performed pre- and postoperatively to assess short and long term outcome. No lymphedema occurred after microsurgical primary preventive approach in the T- group. Significant (average 80% reduction of pre-op excess volume) reduction of lymphedema resulted after microsurgical treatment for secondary leg lymphedema. Post-operative lymphoscintigraphy in 35 patients demonstrated patency of microsurgical anastomoses in all cases with an average follow-up of 42 months. Study results demonstrate that microsurgical LVA primary prevention prevented lymphedema after inguinal lymphadenectomy in the T-group patients. In addition, lymphatic-venous multiple anastomoses proved to be a successful treatment for clinical lymphedema with particular success if treated at the early stages.

Entities:  

Mesh:

Year:  2013        PMID: 23930438

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  8 in total

1.  Lymphedema surgery: the current state of the art.

Authors:  Jay W Granzow
Journal:  Clin Exp Metastasis       Date:  2018-07-06       Impact factor: 5.150

Review 2.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

Review 3.  Secondary lymphedema from cancer therapy.

Authors:  Michael Bernas; Saskia R J Thiadens; Paula Stewart; Jay Granzow
Journal:  Clin Exp Metastasis       Date:  2021-05-05       Impact factor: 5.150

4.  Near-Infrared Fluorescence Lymphatic Imaging to Reconsider Occlusion Pressure of Superficial Lymphatic Collectors in Upper Extremities of Healthy Volunteers.

Authors:  Jean-Paul Belgrado; Liesbeth Vandermeeren; Sophie Vankerckhove; Jean-Baptiste Valsamis; Julie Malloizel-Delaunay; Jean-Jacques Moraine; Fabienne Liebens
Journal:  Lymphat Res Biol       Date:  2016-05-11       Impact factor: 2.589

5.  Primary Prevention of Cancer-Related Lymphedema Using Preventive Lymphatic Surgery: Systematic Review and Meta-analysis.

Authors:  Pedro Ciudad; Joseph M Escandón; Valeria P Bustos; Oscar J Manrique; Juste Kaciulyte
Journal:  Indian J Plast Surg       Date:  2022-02-25

6.  Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.

Authors:  Mirela Mariana Roman; Romain Barbieux; Jean-Marie Nogaret; Pierre Bourgeois
Journal:  World J Surg Oncol       Date:  2018-04-10       Impact factor: 2.754

7.  Prevention of Secondary Lymphedema after Complete Lymph Node Dissection in Melanoma Patients: The Role of Preventive Multiple Lymphatic-Venous Anastomosis in Observational Era.

Authors:  Eleonora Nacchiero; Michele Maruccia; Fabio Robusto; Rossella Elia; Alessio Di Cosmo; Giuseppe Giudice
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

8.  Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up.

Authors:  Joost A G N Wolfs; Luuke G E H de Joode; René R W J van der Hulst; Shan S Qiu
Journal:  Breast Cancer Res Treat       Date:  2019-09-21       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.